Revelation Biosciences, Inc. · NASDAQ:REVB
Rolke James received 208,076 Revelation Biosciences, Inc. shares as an award (Form 4)
Traded Aug 17, 2026 · Filed Aug 18, 2026
On Aug 17, 2026, Rolke James (Director, Chief Executive Officer) received 208,076 Revelation Biosciences, Inc. shares as an award, leaving 422,814 shares. Filed Aug 18, 2026 (Form 4).
- Awarded
- 208,076 shares
- Holding after
- 422,814 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | Award | 208,076 | 422,814 | Direct |
Source
Related
- Revelation Biosciences, Inc.
- Rolke James
- Revelation Biosciences, Inc. shareholders
- Form 4 · Rolke James · May 1, 2026
- Form 4 · Chawla Lakhmir S · Aug 18, 2026
- Form 4 · Zygmont Chester Stanley III · Aug 18, 2026
- Form 4 · Roper Jess · Aug 18, 2026
- Form 4 · Carver Jennifer · Aug 18, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026